BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khuanjing T, Palee S, Chattipakorn SC, Chattipakorn N. The effects of acetylcholinesterase inhibitors on the heart in acute myocardial infarction and heart failure: From cells to patient reports. Acta Physiol (Oxf) 2020;228:e13396. [PMID: 31595611 DOI: 10.1111/apha.13396] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Indorf P, Patzak A, Lichtenberger FB. Drug metabolism in animal models and humans: Translational aspects and chances for individual therapy. Acta Physiol (Oxf) 2021;233:e13734. [PMID: 34637592 DOI: 10.1111/apha.13734] [Reference Citation Analysis]
2 He X, Liu J, Zang WJ. Mitochondrial homeostasis and redox status in cardiovascular diseases: Protective role of the vagal system. Free Radic Biol Med 2022;178:369-79. [PMID: 34906725 DOI: 10.1016/j.freeradbiomed.2021.12.255] [Reference Citation Analysis]
3 Khuanjing T, Ongnok B, Maneechote C, Siri-Angkul N, Prathumsap N, Arinno A, Chunchai T, Arunsak B, Chattipakorn SC, Chattipakorn N. Acetylcholinesterase inhibitor ameliorates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis. Pharmacol Res 2021;173:105882. [PMID: 34530122 DOI: 10.1016/j.phrs.2021.105882] [Reference Citation Analysis]
4 Li M, Zheng C, Kawada T, Inagaki M, Uemura K, Sugimachi M. Intracerebroventricular infusion of donepezil prevents cardiac remodeling and improves the prognosis of chronic heart failure rats. J Physiol Sci 2020;70:11. [PMID: 32066375 DOI: 10.1186/s12576-020-00739-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hsieh M, Chen D, Lee C, Wu C, Chen Y, Huang Y, Chang S. Association Between Cholinesterase Inhibitors and New-Onset Heart Failure in Patients With Alzheimer's Disease: A Nationwide Propensity Score Matching Study. Front Cardiovasc Med 2022;9:831730. [DOI: 10.3389/fcvm.2022.831730] [Reference Citation Analysis]
6 Cacabelos R. Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia. Int J Mol Sci 2020;21:E3059. [PMID: 32357528 DOI: 10.3390/ijms21093059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Nasser MI, Zhu S, Huang H, Zhao M, Wang B, Ping H, Geng Q, Zhu P. Macrophages: First guards in the prevention of cardiovascular diseases. Life Sci 2020;250:117559. [PMID: 32198051 DOI: 10.1016/j.lfs.2020.117559] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
8 Cacabelos R. Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer's disease. Expert Opin Drug Metab Toxicol 2020;16:673-701. [PMID: 32520597 DOI: 10.1080/17425255.2020.1779700] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
9 Wang H, Zong Y, Han Y, Zhao J, Liu H, Liu Y. Compared of efficacy and safety of high-dose donepezil vs standard-dose donepezil among elderly patients with Alzheimer’s disease: a systemic review and meta-analysis. Expert Opinion on Drug Safety. [DOI: 10.1080/14740338.2022.2027905] [Reference Citation Analysis]
10 Cavalcante GL, Brognara F, Oliveira LVC, Lataro RM, Durand MT, de Oliveira AP, da Nóbrega ACL, Salgado HC, Sabino JPJ. Benefits of pharmacological and electrical cholinergic stimulation in hypertension and heart failure. Acta Physiol (Oxf) 2021;232:e13663. [PMID: 33884761 DOI: 10.1111/apha.13663] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]